1 |
Rebustini et al. |
Development |
2012 |
22115756 |
miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. |
2 |
Cochrane et al. |
Mol. Cancer Ther. |
2009 |
19435871 |
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. |
3 |
Prislei et al. |
BMC Cancer |
2013 |
23394580 |
MiR-200c and HuR in ovarian cancer. |
4 |
Liu et al. |
Biomaterials |
2013 |
23806972 |
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. |
5 |
Cochrane et al. |
J Oncol |
2010 |
20049172 |
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. |
6 |
et al. |
|
None |
21207483 |
|
7 |
Lo et al. |
J. Pathol. |
2011 |
21294122 |
MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. |
8 |
Cao et al. |
Cancer Cell |
2011 |
21840484 |
Coordinated regulation of polycomb group complexes through microRNAs in cancer. |
9 |
Shimono et al. |
Cell |
2009 |
19665978 |
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. |
10 |
Park et al. |
Genes Dev. |
2008 |
18381893 |
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. |
11 |
Iorio et al. |
Cancer Res. |
2007 |
17875710 |
MicroRNA signatures in human ovarian cancer. |
12 |
Hyun et al. |
Cell |
2009 |
20005803 |
Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. |
13 |
Mees et al. |
Int. J. Cancer |
2010 |
19569050 |
EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. |
14 |
Howe et al. |
Breast Cancer Res. |
2011 |
21501518 |
Targets of miR-200c mediate suppression of cell motility and anoikis resistance. |
15 |
Brabletz et al. |
EMBO J. |
2011 |
21224848 |
The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. |
16 |
Schickel et al. |
Mol. Cell |
2010 |
20620960 |
miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. |
17 |
Sass et al. |
BMC Syst Biol |
2011 |
21867514 |
MicroRNAs coordinately regulate protein complexes. |
18 |
Park et al. |
Gynecol. Oncol. |
2012 |
22015043 |
The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma. |
19 |
Senanayake et al. |
Carcinogenesis |
2012 |
22431721 |
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. |
20 |
Kopp et al. |
PLoS ONE |
2012 |
23209748 |
miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. |
21 |
Adam et al. |
Clin. Cancer Res. |
2009 |
19671845 |
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. |
22 |
Cai et al. |
Graefes Arch. Clin. Exp. Ophthalmol. |
2012 |
22183793 |
MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. |
23 |
Zhu et al. |
Cancer Chemother. Pharmacol. |
2012 |
21993663 |
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. |
24 |
Chuang et al. |
Endocr. Relat. Cancer |
2012 |
22685266 |
miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. |
25 |
Panda et al. |
Reprod Sci |
2012 |
22569286 |
Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. |
26 |
Oishi et al. |
Hepatology |
2012 |
22707408 |
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. |
27 |
Chuang et al. |
PLoS ONE |
2014 |
24755559 |
miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. |
28 |
Hur et al. |
Gut |
2013 |
22735571 |
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. |
29 |
Lin et al. |
J. Cell. Biochem. |
2013 |
22991189 |
miR-200c enhances radiosensitivity of human breast cancer cells. |
30 |
Farazi et al. |
Genome Biol. |
2014 |
24398324 |
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
31 |
Lerner et al. |
PLoS ONE |
2012 |
22615771 |
MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors. |
32 |
Kishore et al. |
Nat. Methods |
2011 |
21572407 |
A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
33 |
Howe et al. |
PLoS ONE |
2012 |
23185507 |
miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. |
34 |
Luna et al. |
PLoS ONE |
2012 |
23272142 |
Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. |
35 |
Helwak et al. |
Cell |
2013 |
23622248 |
Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. |
36 |
Cesi et al. |
Cell Cycle |
2011 |
22101269 |
TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. |
37 |
Huh et al. |
Br. J. Cancer |
2013 |
23807165 |
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. |
38 |
Li et al. |
Mol. Cancer |
2014 |
24997798 |
miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. |
39 |
Li et al. |
Mol. Carcinog. |
2014 |
23065816 |
G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. |
40 |
Chang et al. |
Pathol. Oncol. Res. |
2014 |
23821457 |
MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE. |
41 |
Tang et al. |
Clin. Cancer Res. |
2013 |
23995857 |
miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. |
42 |
Luo et al. |
J Transl Med |
2013 |
23497265 |
A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells. |
43 |
Whisnant et al. |
MBio |
2013 |
23592263 |
In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
44 |
Shi et al. |
PLoS ONE |
2013 |
24205206 |
MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. |
45 |
Pacurari et al. |
Int. J. Oncol. |
2013 |
23708087 |
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. |
46 |
Bai et al. |
Int. J. Cancer |
2014 |
24615544 |
MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. |
47 |
Memczak et al. |
Nature |
2013 |
23446348 |
Circular RNAs are a large class of animal RNAs with regulatory potency. |
48 |
Hafner et al. |
Cell |
2010 |
20371350 |
Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
49 |
Gottwein et al. |
Cell Host Microbe |
2011 |
22100165 |
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
50 |
Lipchina et al. |
Genes Dev. |
2011 |
22012620 |
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
51 |
Li et al. |
Int. J. Pediatr. Otorhinolaryngol. |
2013 |
23294929 |
MicroRNA expression profiling and target genes study in congenital microtia. |
52 |
Yang et al. |
J. Clin. Invest. |
2014 |
24762440 |
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. |
53 |
Luo et al. |
Cancer Res. |
2014 |
24786790 |
Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. |
54 |
Kopp et al. |
Oncotarget |
2014 |
24368337 |
The proto-oncogene KRAS is targeted by miR-200c. |
55 |
Cama et al. |
Acta Neuropathol. |
2013 |
23955600 |
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. |
56 |
Huang et al. |
Stem Cell Res |
2014 |
24365599 |
miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation. |
57 |
Peng et al. |
Br. J. Cancer |
2013 |
24169343 |
Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. |
58 |
Sun et al. |
Int. J. Cancer |
2015 |
25044403 |
MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. |
59 |
Tao et al. |
Biochim. Biophys. Acta |
2014 |
25017995 |
Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development. |
60 |
Skalsky et al. |
PLoS Pathog. |
2012 |
22291592 |
The viral and cellular microRNA targetome in lymphoblastoid cell lines. |
61 |
Karginov et al. |
Genes Dev. |
2013 |
23824327 |
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
62 |
Xue et al. |
Cell |
2013 |
23313552 |
Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
63 |
Chi et al. |
Nature |
2009 |
19536157 |
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |